Invention Application
- Patent Title: BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
-
Application No.: US15541594Application Date: 2016-01-08
-
Publication No.: US20170355767A1Publication Date: 2017-12-14
- Inventor: Patrick ENGELBERTS , Esther BREIJ , Rik RADEMAKER , Isil ALTINTAS , David SATIJN , Sandra VERPLOEGEN , Riemke VAN DIJKHUIZEN RADERSMA , Edward VAN DEN BRINK , Janine SCHUURMAN , Paul PARREN
- Applicant: GENMAB A/S
- Priority: EPPCT/EP2015/050276 20150108; DKPA201500412 20150715; DKPA201500413 20150715; DKPA201500415 20150716; DKPA201500416 20150716
- International Application: PCT/EP2016/050296 WO 20160108
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395
Abstract:
Bispecific antibodies directed to CD3 and CD20 and uses of such bispecific antibodies, in particular use thereof in the treatment of diseases in which specific targeting and T cell-mediated killing of cells that express CD20 is desired.
Public/Granted literature
- US10544220B2 Bispecific antibodies against CD3 and CD20 Public/Granted day:2020-01-28
Information query
